These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis]. Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273 [TBL] [Abstract][Full Text] [Related]
4. Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers. Chadwick SL; Kingston HD; Stern M; Cook RM; O'Connor BJ; Lukasson M; Balfour RP; Rosenberg M; Cheng SH; Smith AE; Meeker DP; Geddes DM; Alton EW Gene Ther; 1997 Sep; 4(9):937-42. PubMed ID: 9349430 [TBL] [Abstract][Full Text] [Related]
5. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. Zabner J; Cheng SH; Meeker D; Launspach J; Balfour R; Perricone MA; Morris JE; Marshall J; Fasbender A; Smith AE; Welsh MJ J Clin Invest; 1997 Sep; 100(6):1529-37. PubMed ID: 9294121 [TBL] [Abstract][Full Text] [Related]
6. Cationic lipid:pDNA complexes for the treatment of cystic fibrosis. Eastman SJ; Scheule RK Curr Opin Mol Ther; 1999 Apr; 1(2):186-96. PubMed ID: 11715942 [TBL] [Abstract][Full Text] [Related]
11. Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung. McLachlan G; Davidson H; Holder E; Davies LA; Pringle IA; Sumner-Jones SG; Baker A; Tennant P; Gordon C; Vrettou C; Blundell R; Hyndman L; Stevenson B; Wilson A; Doherty A; Shaw DJ; Coles RL; Painter H; Cheng SH; Scheule RK; Davies JC; Innes JA; Hyde SC; Griesenbach U; Alton EW; Boyd AC; Porteous DJ; Gill DR; Collie DD Gene Ther; 2011 Oct; 18(10):996-1005. PubMed ID: 21512505 [TBL] [Abstract][Full Text] [Related]
12. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884 [TBL] [Abstract][Full Text] [Related]
13. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Noone PG; Hohneker KW; Zhou Z; Johnson LG; Foy C; Gipson C; Jones K; Noah TL; Leigh MW; Schwartzbach C; Efthimiou J; Pearlman R; Boucher RC; Knowles MR Mol Ther; 2000 Jan; 1(1):105-14. PubMed ID: 10933918 [TBL] [Abstract][Full Text] [Related]
14. A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea. Goddard CA; Ratcliff R; Anderson JR; Glenn E; Brown S; Gill DR; Hyde SC; MacVinish LJ; Huang L; Higgins CF; Cuthbert AW; Evans MJ; Colledge WH Gene Ther; 1997 Nov; 4(11):1231-6. PubMed ID: 9425447 [TBL] [Abstract][Full Text] [Related]
15. Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways. Rose AC; Goddard CA; Colledge WH; Cheng SH; Gill DR; Hyde SC Gene Ther; 2002 Oct; 9(19):1312-20. PubMed ID: 12224014 [TBL] [Abstract][Full Text] [Related]
16. [Gene therapy of hereditary diseases]. Ginter EK Vopr Med Khim; 2000; 46(3):265-78. PubMed ID: 11033886 [TBL] [Abstract][Full Text] [Related]
17. Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway. Zhang LN; Karp P; Gerard CJ; Pastor E; Laux D; Munson K; Yan Z; Liu X; Godwin S; Thomas CP; Zabner J; Shi H; Caldwell CW; Peluso R; Carter B; Engelhardt JF Mol Ther; 2004 Dec; 10(6):990-1002. PubMed ID: 15564131 [TBL] [Abstract][Full Text] [Related]
18. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice. Ostrowski LE; Yin W; Diggs PS; Rogers TD; O'Neal WK; Grubb BR Gene Ther; 2007 Oct; 14(20):1492-501. PubMed ID: 17637798 [TBL] [Abstract][Full Text] [Related]